Issa Mohamed Khairie 4
4 · INCYTE CORP · Filed Jan 8, 2025
Insider Transaction Report
Form 4
INCYTE CORPINCY
Issa Mohamed Khairie
EVP, Head of US Oncology
Transactions
- Award
Common Stock
2025-01-06+48,671→ 48,671 total
Footnotes (2)
- [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- [F2]Includes the January 6, 2025 aggregate grant of 48,671 shares of common stock.